The study titled “Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity” investigates the potential anti-tumor effects of frankincense essential oil, which is obtained from the hardened gum resin of Boswellia trees and has a long history of traditional use. The researchers tested the effects of the oil on human bladder cancer cells (J82) and compared these to its effects on normal bladder urothelial cells (UROtsa). They found that frankincense oil significantly reduced the viability of cancerous J82 cells in a dose-dependent manner while having minimal impact on the normal urothelial cells, suggesting a degree of selectivity for malignant cells. Gene expression profiling further indicated that the oil activated pathways related to cell cycle arrest and growth suppression in the cancer cells, although classical indicators of apoptosis, like DNA fragmentation, were not observed in this system.
Based on these findings, the authors conclude that frankincense oil can distinguish between bladder cancer cells and normal cells and effectively suppress tumor cell viability through multiple molecular pathways. This selective cytotoxicity, supported by comprehensive microarray and bioinformatics analyses, suggests that frankincense oil could have potential as an alternative intravesical therapeutic agent for bladder cancer treatment, warranting further research into its mechanisms and clinical applicability.
PMID: 19296830